Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders-Reference-Cited by-同舟云学术

Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders

Published:2021-12 Issue: Volume:157 Page:106587
ISSN:1098-8823
Container-title:Prostaglandins & Other Lipid Mediators
language:en
Short-container-title:Prostaglandins & Other Lipid Mediators

Author:

Razavi Seyed Mehrad^ORCID,Khayatan Danial^ORCID,Arab Zahra Najafi^ORCID,Momtaz Saeideh,Zare Kimia,Jafari Razieh Mohammad,Dehpour Ahmad Reza,Abdolghaffari Amir Hossein^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Pharmacology,Physiology,Biochemistry

Reference84 articles.

1. Effect of licofelone—a dual COX/5-LOX inhibitor in intracerebroventricular streptozotocin-induced behavioral and biochemical abnormalities in rats;Kumar;J. Mol. Neurosci.,2015

2. Effect of cinnamon essential oil on gut microbiota in the mouse model of dextran sodium sulfate-induced colitis;Li;Microbiol. Immunol.,2020

3. Licofelone attenuates MPTP-induced neuronal toxicity: behavioral, biochemical and cellular evidence;Gupta;Inflammopharmacology,2010

4. Berberine as a potential autophagy modulator;Mohammadinejad;J. Cell. Physiol.,2019

5. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6;Campbell;Proc. Natl. Acad. Sci. U. S. A.,1993

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Licofelone, a Dual COX/LOX Inhibitor, Ameliorates Paclitaxel-Induced Mechanical Allodynia in Rats in a Cannabinoid Receptor-Dependent Manner;Biomedicines;2024-07-11

2. Plasma oxylipin profiles reflect Parkinson's disease stage;Prostaglandins & Other Lipid Mediators;2024-04

3. Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5- LOX by molecular docking and dynamic simulation approaches;Computers in Biology and Medicine;2024-03

4. Protective Effects of Plant-Derived Compounds Against Traumatic Brain Injury;Molecular Neurobiology;2024-03-01

5. Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis;Arthritis Research & Therapy;2023-09-20